{
    "nct_id": "NCT02624804",
    "official_title": "A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes",
    "inclusion_criteria": "* Adult patients >/=18 years\n* Must have a diagnosis of type 1 diabetes mellitus based on the 2015 American Diabetes Association criteria for the Clarification and Diagnosis of diabetes\n* Must have a blood test confirming the presence of at least one autoantibody to pancreatic islet cells (IAA, IA2, GAD 65, ZnT8)\n* Fasting C-peptide level > 0.3 ng/ml\n* Adequate venous access for apheresis\n* Ability to provide informed consent\n* Must agree to comply with all study requirements and be willing to complete all study visits\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* AST or ALT 2 > x upper limit of normal.\n* Creatinine > 2.0 mg/dl.\n* Known coronary artery disease or EKG suggestive of coronary artery disease unless cardiac clearance for apheresis is obtained from a cardiologist.\n* Known active infection\n* Pregnancy or breastfeeding mothers\n* Use of immunosuppressive medication within one month of enrollment including but not limited to prednisone, cyclosporine, tacrolimus, sirolimus, and chemotherapy.\n* Presence of any other autoimmune diseases (lupus, rheumatoid arthritis, scleroderma, etc.)\n* Anticoagulation other than ASA.\n* Hemoglobin < 10 g/dl or platelets < 100 k/ml\n* Is unable or unwilling to provide informed consent\n* Presence of any other physical or psychological medical condition that, in the opinion of the investigator, would preclude participation",
    "miscellaneous_criteria": ""
}